E., Kamiya, T., Kawada, Y., Renshaw, P
Tirzepatide, a dual GIP/GLP-1 receptor agonist, has demonstrated a greater reduction in HbA1c (up to 2.4%) than conventional GLP-1 agonists [4]
It's important to note that as you lose weight, your calorie needs will decrease, and your target may need periodic adjustment
Sermorelin has none of that adult-specific clinical validation
Better glycemic control Thyroid function significantly affects insulin sensitivity
Eligible studies were English-language original research articles, reviews, or meta-analyses involving human PCOS populations or relevant cellular/animal models with mechanistic relevance